Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0371919890020010025
Journal of Wonju College of Medicine
1989 Volume.2 No. 1 p.25 ~ p.32
In Vitro Susceptibility of Cryptococcus neoformans to Amphotericin B, 5-Fluorocytosine, Ketoconazole, Miconazole and Rifampicin Alone and in Combination


Abstract
In vitro activities of experimental antifungal agents were studied to determine the minimum inhibitory concentrations and possible drug interaction in combination of amphotericin B/ketocoazole, amphotericin B/miconazole, ketoconazole/miconazole, ketoconazole/rifampicin and miconazole/rifampicin.
The minimum inhibitory concentrations of 5 experimental antifungal agents for these strains were ranged as amphotericin B; 0.39 mcg/§¢-1.56mcg/§¢, 5-fluorocytosine; 0.25mcg/§¢-6.25mcg/§¢, ketoconazole; 0.047mcg/§¢-0.0094mcg/§¢, miconazole; 0.78mcg/§¢-1.56mcg/§¢ and rifampicin; >100.0mcg/§¢. in all of the strains, ketoconazole had a greatest antifungal activity on the dilutioin basis.
When a checkerboard technique was used amphotericin B acted synergistically with ketoconazole and miconazole whereas rifampicin had no synergistic effect.
In the cases of ketoconazole (0.023mcg/§¢) and miconazol (0.39 mcg/§¢) can be found only indifferent activity.
KEYWORD
FullTexts / Linksout information
Listed journal information